Medicated personal care products are an offshoot of the global personal care products industry and are likely to become increasingly popular over the coming years. Medicated personal care products contain medications that help protect the skin and hair from various disorders. This makes them more functional than normal personal care products, which don’t contain active medications. Medicated personal care products are becoming increasingly popular in the global personal care industry due to their multifunctionality and benefits.
The global Medicated skin Care Products Market is likely to grow at a promising rate over the forecast period till 2027, according to Market Research Future (MRFR). The latest research report from Market Research Future (MRFR) examines the global medicated personal care products market from top to bottom, providing a comprehensive overview of the market’s leading drivers and restraints and how they are likely to affect the market going forth. The economic background of the global medicated personal care products market is also explained in detail in the report, providing context for the analysis regarding the major drivers and restraints affecting the global market. Leading players operating in the global medicated personal care products market are also profiled in the report. The growing personal care products industry is likely to be a major driver for the global medicated personal care products market over the forecast period. Personal care products have become widely popular with urban consumers in the last few years, as they help users maintain an attractive appearance. The growing problem of pollution in urban areas around the world has also led to a growing demand from the personal care products market, as personal care products help users protect their skin and hair from toxic air pollutants. Medicated personal care products go further along the line and protect the skin and hair from toxic pollutants to a greater degree than normal personal care products. This is likely to drive the demand from the medicated personal care products market over the forecast period. Segmentation: The global medicated personal care products market is segmented on the basis of type, beauty care, and region. The global medicated personal care products market is segmented on the basis of type into antiperspirants, deodorants, oral care, hand sanitizer, natural personal care products, and others. By beauty care, the global medicated personal care products market is segmented into oils, shampoos, moisturizers, gels, soaps, and others. Regional Analysis: North America is the leading regional market for medicated personal care products. The presence of several leading players in the medicated personal care products market in North America has helped the regional market accrue a strong share in the global medicated personal care products market over the past few years. Medicated personal care products were first developed in North America and the region still accounts for a major share in the production and distribution of medicated personal care products. This leads to the region holding a strong share in the global medicated personal care products market. The growing pollution problem in major American cities and the growing awareness about medicated personal care products among the general populace is a major driver for the North America medicated personal care products market. Europe is also a leading regional market for medicated personal care products and is likely to account for a sizeable share in the global market over the forecast period. However, Asia Pacific is likely to be the hub of the action in the global medicated personal care products market over the forecast period, as the growing pollution in urban areas in Asia Pacific and the rising disposable income of consumers in the region are likely to lead to steady growth in the medicated personal care products market in the region over the forecast period. Read full report @ Competitive Analysis: https://www.marketresearchfuture.com/reports/medicated-personal-care-products-market-1008 Leading players in the global medicated personal care products market include DCC Health and Beauty Solutions Ltd., L’Oreal, Johnson & Johnson, Edana, KPH Cosmos Pvt. Ltd., TWASA, and Personal Care. In December 2019, Scott’s Liquid Gold announced the sale of its personal care product manufacturing facility in Denver, Colorado to Elevation Labs Colorado. In July 2019, the European Commission approved the sale of Pfizer’s consumer health business to GSK. Related reports Pharmaceutical Excipients Market Digestible Sensors Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: www.marketresearchfuture.com
0 Comments
Preimplantation Genetic Testing Market Revolutionary Opportunities 2023 - Business Insights7/6/2020 It is estimated that the global preimplantation genetic testing market is expected to register a CAGR of 10.2% during the forecast period of 2019 to 2025, with a market value of USD 375.8 million in 2018.
Preimplantation genetic testing is the testing at the pre-implantation stage for detection of genetic defects in embryos or oocytes. Preimplantation genetic testing has occurred more frequently in recent years in North America and Europe, due to the advancement in genetic technology. The decreasing fertility rates worldwide enhance the acceptance of the preimplantation genetic testing to avoid further complications of chromosomal abnormalities with advancing maternal age. This leads to the growth of the preimplantation genetic testing market during the forecast period. According to the Vital Statistics Rapid Release, the total fertility rate for the US in 2017 was 1,764.5 births per 1,000 women, and in 2016 it was 1,820.5, which is 3% less, this shows the reduction in the rate of fertility. An increasing number of fertility clinics worldwide, new development technological advancements in the field of genetic analysis and high threat of chromosomal abnormalities with advancing maternal age are the other driving factors for global preimplantation genetic testing market The global Preimplantation Genetic Testing Market size is segmented based on procedure, type, application, technology, product and service, end user, and region. The global market for preimplantation genetic testing, by procedure, is segmented into preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS). Hundred different genetic conditions can be tested with Preimplantation Genetic Diagnosis (PGD) which enables the couple to have a baby with no genetic defect thus the segment is expected to hold the largest market share owing to rising awareness population and healthcare experts. Preimplantation Genetic Screening (PGS) segment is also anticipated to grow profitably to increase healthy pregnancy. By type, embryo testing segment is expected to show favorable growth as the threat of chromosomal abnormalities increases. By product and service, the reagents and consumables segment anticipated to hold the largest market share as there is continuous declination infertility of female due to increasing usage of reagents for the diagnosis. By technology, the next-generation sequencing segment, and comparative genomic hybridization also expected to hold large share as its cost is reduced and its capability to detect mosaicism. The market by end user has been segmented into maternity centers & fertility clinics hospitals, diagnostic labs and research laboratories & academic institutes. Based on region, the global preimplantation genetic testing market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Key Players Some of the major players in the global preimplantation genetic testing market are Natera, Inc.CooperSurgical, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., IGENOMIX, Reprogenetics, LLC, Genea Limited, PerkinElmer, Inc., Genesis Genetics Ltd., Quest Diagnostics Incorporated, Thermo FisherScientific, Inc, Bioarrayn Genetics, Laboratory Corporation of America Holdings, California Pacific Medical Center and Reproductive Health Science Ltd OBTAIN RESEARCH REPORT DETAILS WITH TOC @https://www.marketresearchfuture.com/reports/preimplantation-genetic-testing-market-8121 Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ Musculoskeletal System Disorders Market Trends growth Share, Analysis, Global Industry Demand7/6/2020 The Global Musculoskeletal System Disorders Market is projected to register a CAGR of 5.3% to reach an estimated USD 5.73 billion by 2025. The growth of global musculoskeletal system disorders market is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are expected to curb the growth of the global musculoskeletal system disorders market.
The rising number of cases of work-related musculoskeletal system disorders in developing nations and an increase in the geriatric population in developed nations are driving the growth of the market. Musculoskeletal System Disorders Market Key Players: Some of the key players in the global Musculoskeletal System Disorders Market size are
Americas: The largest regional market.
Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ Industry Report “Antibiotics Market Research Report - Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.
Market Synopsis Supportive government legislations, such as the implementation of the Generating Antibiotics Incentives Now (GAIN) Act in the US, are expected to accelerate the drug approval process in the antibiotics market size Key Players Some of the key players in the Global Antibiotics Market are Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Astellas Pharma Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Johnson & Johnson Services, Inc. (US), Abbott Laboratories (US), GlaxoSmithKline PLC (UK), Sanofi (France), Bayer AG (Germany), Eli Lilly and Company (US), and Merck & Co., Inc. (US). Segmentation The global antibiotics market has been segmented based on drug class, spectrum of activity, drug origin, and end user. The market, based on drug class, has been divided into cephalosporins, penicillin, fluoroquinolones, macrolides, carbapenem, aminoglycosides, sulfonamides, and others. The carbapenem segment is likely to be the fastest growing during the review period due to the increasing incidence of pneumonia, urinary tract infections, which would increase the usage of the carbapenem class of antibiotics. Thus, the rising usage of carbapenem will substantially drive the growth of the antibiotics market. The global antibiotics market has been bifurcated, based on spectrum of activity, into broad-spectrum antibiotics and narrow-spectrum antibiotics. The broad-spectrum antibiotic segment is expected to hold the majority share of the market as this broad-spectrum antibiotic act against a wide range of diseases, which helps to fight against microbial resistance. Get Full Report @ www.marketresearchfuture.com/reports/antibiotics-market-8447 Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing adoption of antibiotics. The antibiotics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European antibiotics market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Related News Vitiligo Treatment Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Global Perfusion Imaging Market Analysis, Guidelines Overview and Upcoming Trends Forecast 202411/5/2019 The Global Perfusion Imaging Market is expected to register a CAGR of 6.34% during the forecast period, with a market value of USD 5,404.31 Million in 2018 Leading Market Players General Electric Company (US), Siemens (Germany), Medtronic (Ireland), Canon Medical Systems Corporation (Japan), Bracco Diagnostic, Inc. (Italy), Koninklijke Philips NV (Netherlands), Neusoft Corporation (China), lantheus Medical Imaging, Inc. (US), Shimadzu Corporation (Japan), Aetna (US), Perimed (US), Advantis Medical Imaging (Netherland), and others. Obtain Detailed Report Information along with TOC@ https://www.marketresearchfuture.com/reports/perfusion-imaging-market-3511 Market Overview Mortuaries are places where corpses are preserved and stored for autopsies or educational and research purposes. Many equipment is used in mortuaries for preservation and for storing the cadavers for research and education. The intensified levels of demand being detected for non-invasive diagnostic procedures have promoted the progress of the market considerably. The rise in the number of chronic diseases such as brain tumors and cardiac diseases has amplified the progress of the market noticeably. Furthermore, upsurge in the number of geriatric population will fuel the growth of the market significantly over the forecast period. Segmentation : Perfusion Imaging Market By methods, the market has been segmented into computed tomography (CT), microspheres, nuclear medicine, magnetic resonance imaging (MRI), and other. Based on the applications, the market has been segmented into functional brain imaging, myocardial perfusion imaging, ventilation perfusion imaging, testicular torsion detection and other Key Questions Answered in This Report: • What will the market size and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? Competitive Analysis The innovation in products and services of the markets will alter the progression of the market substantially. The market appeal and competitors’ tendencies are noticeably improved by the strategies that are being exploited by market players. The market is significantly elevated by the developments that are occurring in the market. The critical success factors in the market are easily achieved in the market leading to a raised pace of development in the forecast period. Browse other healthcare-related report Infection Control Market – Global Forecast 2017 - 2023 About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact Email: [email protected] Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth. Segmentation on the basis of diagnosis, treatment, and end users.
Get a free sample @ https://www.marketresearchfuture.com/sample_request/5343 Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Laboratories Market Research and Consulting Service Providers Regional Analysis The Americas dominate the global Merkel cell carcinoma market. Presence of a well-developed healthcare sector and high per capita healthcare expenditures provides favorable backgrounds for market growth within the region. Additionally, the presence of the major market players within the region fuels the market growth. Followed by the Americas, Europe leads the Merkel cell carcinoma market. Availability of funds for research, huge patient population, and government support for research & development is estimated to drive the market growth within the region. Asia Pacific is the fastest growing region for the market due to the presence of economies like India, Australia, and China and developing healthcare sector in the market. Increasing prevalence of skin cancer, growing geriatric population, and rising healthcare expenditure boost the market growth within the region. On the other hand, the Middle East & Africa has the least share in the Merkel cell carcinoma market due to the presence of poor economies and stringent government policies, especially in the African region. Majority of the market of this region is held by the Middle East. Key Players Pfizer Inc. (U.S.) Merck & Co., Inc. (U.S.) OncoSec Medical Incorporated (U.S.) Bristol-Myers Squibb Company (U.S.) General Electric Company (U.S.) Siemens Medical Solutions USA, Inc. (Germany) CANON MEDICAL SYSTEMS CORPORATION (Japan) Philips Health Care (The Netherlands) AstraZeneca (U.K) Mediso Ltd. Endomagnetics Limited (Hungary) Browse Full Report @ https://www.marketresearchfuture.com/reports/merkel-cell-carcinoma-market-5343 . About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: [email protected] . Global Legg-Calve-Perthes Disease Treatment Market: Type (Surgical and Non-Surgical Methods), Application (Osteoarthritis, Hip Dislocation, Hip Fracture), Age Group (4-6, 6-11 and 12-19 years), End-User (Hospitals and Clinics)–Global Forecast Till 2023 Legg-Calve-Perthes is a disease which occurs when the blood supply to the femoral head (upper end of the thigh bone) which fits in the hip socket temporarily stops to flow. As an outcome, the femoral head is no longer round and does not move smoothly in the hip socket, resulting in hip pain and constrained leg movements. Individuals suffering from the disease go on developing a painful joint disorder called as hip osteoarthritis at an early age. Rising frequencies of hip osteoarthritis due to the increasing number of elderly population and increase in health care expenditure are expected to boost the Legg-Calve-Perthes Disease Treatment Market growth during the forecast period. The side effects of the treatment and strict monitoring policies for management of drugs will hamper the market growth. The global legg-calve-Perthes disease treatment market is expected to register a significant growth during the forecast period (2018–2023). Key Players of the market · BASF, · Albemarle, · Sunline, · IOLCP, · Shandong Xinhua Pharmaceutical Co. Ltd, · Dr. Reddy's, · DePuy Synthes, · Prime Medical, · Zimmer, · Biomet Holdings, Inc., · 3M Healthcare, · Össur Hf, · DJO, · Stryker Corporation. Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/6345 Segmentation The global legg-calve-perthes disease treatment market has been segmented on the basis of type, application, age group, and end-users. On the basis of type, the market has been classified as non-surgical and surgical methods. The non-surgical method is segmented in to anti-inflammatory medications, casting and bracing, crutches, and others. Casting and bracing is further segmented into newington brace, toronto orthosis, scottish rite orthosis, broomstick plasters, and birmingham orthosis. The others segment is further sub-segmented in to conventional calipers, snyder slings, slings with crutches, and traction. The surgical method is segmented in to femoral osteotomy, innominate osteotomy, combination of femoral osteotomy, and innominate osteotomy. On the basis of application, the market has been classified as hip fracture, hip dislocation, osteoarthritis, and congenital dysplasia of the hip. Intended Audience · Advanced Surgical Trainees · Governmental Agency · Educational Organizations · Medical Device Manufacturers · Research Institutes and Academic Centers · Market Research and Consulting Access the full report @ https://www.marketresearchfuture.com/reports/legg-calve-perthes-disease-market-6345 Regional Analysis The North American region holds the largest share of the market. The change in lifestyle and availability of advanced medical technologies help the market to grow. Healthcare insurance policies are the most important factor that contributes for the growth of the market in this region. The European market is determined by fluctuating government policies to support drug manufacturers to develop advanced treatment options. The changing policies are likely to fuel the revenue growth of the market. The European market accounts to hold the second largest share of the market due to rising patient population. Asia-Pacific is expected to be the fastest growing region. Factors such as huge patient base population and presence of developing economies and medical tourism help to boost the market. Beneficial government strategies and rise in healthcare expenditure also fuel the market growth. About Us: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Media Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: [email protected] Bioburden Testing Market 2019 | Segmentation, Regional Analysis, Global Players and Forecast 20239/19/2019 Bioburden Testing Market - Highlights Bioburden testing refers to an estimation of microbial load on a medical instrument, raw material, packaged goods among others. Several factors such as rising medical spending, increasing food safety concerns and growing product recalls due to microbial contamination are projected to drive the growth of the market. On the other hand, high costs of microbial enumeration instruments and complex and time-consuming regulatory standards in some economies may curb the market growth during the assessment period. The Global Bioburden Testing Market is expected to register a CAGR of Approx. 9.15% during the forecast period of 2018–2023 with an estimated market value of USD 455 million. Moreover, test reports and certificates tend to be different from one country to another which hampers international trade. Therefore, in December 2017, International Organization for Standardization (ISO) published a new edition of ISO/IEC 17025 standard. This standard is an international reference for laboratories carrying out calibration and testing activities around the world. ISO/IEC 17025 helps facilitate cooperation between laboratories and other bodies by creating widespread acceptance of results between countries. The global bioburden testing market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in October 2018, Becton, Dickinson and Company, a leading global medical technology company, announced the availability of the BD MAX MDR-TB (multi-drug resistant tuberculosis) panel in Europe. Get a free sample @ https://www.marketresearchfuture.com/sample_request/6716 Regional Analysis: The market in the Americas is expected to dominate the global bioburden testing market during the forecast period owing to the presence of well-established healthcare system, increasing healthcare expenditure, and favorable reimbursement scenario. The European market is expected to be the second-largest due to availability of funds for research from public and private sources. Moreover, the market in Asia-Pacific is predicted to be the fastest-growing during the assessment period owing to growing disposable income, and continuously developing economies. The market in the Middle East & Africa is likely to account for the smallest share of the global bioburden testing market. The market growth in this region can be attributed to the growing government initiatives. Segmentation: The global bioburden testing market has been segmented into test type, product type, application and end-user. The market, on the basis of type, has been segmented into aerobic count, anaerobic count, fungi count and spore count. The market, on the basis of product type, has been segmented into consumables and instruments. The market, by consumables, has been sub-segmented into reagents and kits, and others. The market, by instruments, has been further segmented into polymerase chain reaction machine (PCR), microscopes, and others. The market, by application, has been segmented into raw materials testing, medical devices testing, in-process material testing, sterilization validation testing, and equipment cleaning validation. The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, microbial testing laboratories, and others. Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/bioburden-testing-market-6716 Key Players: Some of the key players in the global bioburden testing market are WuXi AppTec, Charles River, SGS SA, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs. Contact: Market Research Future +1 646 845 9312 Email: [email protected] . |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2021
Categories |